The book highlights that bringing a new drug to market can take over a decade and cost billions. It also examines how agencies like the FDA and EMA ensure drug safety and efficacy through rigorous regulatory approval processes. Pharmaceutical companies employ various strategies, like patent protection and pricing, to maintain profitability within these constraints.
The book progresses by first covering drug discovery and development, then analyzing regulatory pathways, and finally diving into business strategies and ethical implications. This book stands out by combining scientific, regulatory, and business perspectives, providing a holistic understanding of the pharmaceutical market. It uses industry reports, case studies, and academic research to offer a balanced view.
By examining business models, regulatory frameworks, and scientific advancements, Pharmaceutical Markets aims to provide readers with a balanced perspective on the sectorâs successes, challenges, and societal impact.